Sleep aids tend to work by targeting a single pathway. Sedative drugs bind GABA receptors and suppress neural activity across the board. Melatonin nudges circadian timing. Antihistamines block arousal signals in the brain. Cannabis is unusual because it contains three compounds — THC, CBD, and CBN — that each interact with sleep through different mechanisms, at different points in the night. A formula combining all three is not simply additive. It is an attempt to address the sleep problem from multiple angles simultaneously, with each compound handling something the others cannot do as well on their own.
THC: the fast-acting ingredient
THC is the most effective cannabinoid for reducing sleep onset latency — the time it takes to fall asleep. This is probably its most consistent sleep effect in the research, and it is well-documented. THC activates CB1 receptors in the hypothalamus and brainstem, regions involved in regulating sleep-wake transitions. At moderate doses, most people fall asleep meaningfully faster after THC than without it.
The complication is what happens deeper in the night. At higher doses and with regular use over time, THC suppresses REM sleep — the stage associated with dreaming, emotional processing, and memory consolidation. This is not a subtle effect: research has found that chronic high-dose THC use can reduce REM substantially, with a rebound effect of vivid, intense dreaming when use is stopped and the brain catches up. For occasional or low-dose use, this effect is less pronounced, but it is one reason that maximizing THC in a sleep formula is not necessarily the goal. Getting to sleep faster is valuable; disrupting the architecture of sleep to do it is a meaningful tradeoff.
CBD: the modulator
CBD's role in sleep is less direct and more complex than THC's. It does not bind strongly to CB1 or CB2 receptors in the way THC does. Instead, it modulates those receptors through indirect pathways, interacts with serotonin 5-HT1A receptors involved in anxiety and mood, and affects endocannabinoid reuptake in ways that are still being characterized. At high doses in clinical settings — 150mg and above — CBD has demonstrated both anxiolytic and sleep-supporting effects. At the doses typically present in tincture formulas, its direct sleep effects are subtler. It may primarily work by reducing the anxiety and hyperarousal that make falling asleep difficult in the first place, rather than by producing sedation on its own.
CBD also modifies how THC behaves, and this is probably its most important contribution in a three-compound sleep formula. It reduces THC-related anxiety, blunts the intoxicating peak, and may allow the THC to work effectively at a lower dose than would otherwise be needed. Including CBD in a sleep formula changes the character of the THC component: you can use less THC to achieve the onset effect, which reduces REM suppression and the risk of next-morning grogginess. The two compounds are not simply additive — the combination can do things that neither accomplishes alone.
CBN: the uncertain third
CBN's role in the stack is the most speculative of the three, but the speculation is grounded in something. As covered in more depth in the CBN piece, the compound's sleep reputation traces back primarily to a 1976 study by Paton and Pertwee showing that CBN combined with THC produced greater sedation in mice than THC alone — not that CBN is sedating by itself. This distinction matters: CBN's contribution in a sleep formula may not be direct sedation but potentiation of the THC component, extending or deepening an effect that THC has already initiated.
CBN binds CB1 and CB2 receptors at roughly one-tenth the affinity of THC. At the doses found in commercial products — typically 2 to 10mg — it appears to be mildly psychoactive at most, and does not independently produce reliable sedation in most users. The dose matters: some preclinical work suggests that CBN is not meaningfully sedating at low doses but produces a different effect at higher doses alongside THC. The research remains too thin to be definitive, but the combination mechanism is biologically plausible and consistent with the practical observation that CBN-forward sleep formulas behave differently from THC-only formulas at equivalent THC doses.
Why three compounds instead of one
The three-compound argument is not "more cannabinoids equal more sedation." It is more specific: each compound addresses a different part of the sleep problem, and each helps manage the downsides of the others working alone.
THC drives sleep onset but carries REM-suppression risk at higher doses and the possibility of anxiety in susceptible users. CBD modulates the THC effect — reducing anxiety risk and allowing a lower effective THC dose — but cannot independently produce reliable sleep onset. CBN may extend or deepen the sedative effect and potentially modify how THC interacts with sleep architecture, but does not appear to be strongly sedating without THC present. Together, the formula can produce reliable onset at a lower THC dose than would be needed alone, manage the anxiety vulnerability that makes high-THC sleep aids problematic for some people, and potentially improve the depth and continuity of sleep rather than simply accelerating its arrival.
The result is not faster unconsciousness. It is, ideally, sleep that feels complete — arriving at a reasonable time and staying intact through the night.
What we still do not know
The honest caveat is that the specific interaction of all three compounds in a human sleep formula has not been studied in a well-designed clinical trial. The three-compound sleep stack is a reasonable inference from the existing cannabinoid research, not a clinically proven protocol. Individual variation is high: dose, tolerance, the timing of administration relative to sleep onset, prior cannabis experience, and even whether you ate that evening all affect outcomes. What works consistently for one person may require meaningful adjustment for another.
Finding the right dose involves paying attention to a few variables: onset time (you want to feel the effect arriving, not be surprised by it), sleep quality (grogginess the next morning suggests the dose is too high or the timing is off), and REM character (unusually vivid dreams after stopping are a sign of prior suppression). These are things to observe over days, not to optimize on night one.
Moonrise is the formula built around this stack — with CBN, CBD, and THC at ratios designed to give each compound room to contribute rather than having one dominate. It is the practical version of the argument this article makes.